VetMedGuide

Vet Med Guide

Companion animal beside veterinary diagnostic materials.
Diagnostics2026-06-18 · 12 min read

Feline Hyperthyroidism: T4 Diagnosis, Methimazole vs Radioiodine, and Kidney Monitoring

Feline hyperthyroidism workup — total T4, free T4 by equilibrium dialysis, and TSH; methimazole vs radioiodine (I-131) vs thyroidectomy vs iodine diet; and why kidney function drives the plan.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Feline hyperthyroidism is the most common hormonal disease of older cats, with a reported prevalence of up to roughly 10% in cats over 10 years of age — about one in ten. It was first described in 1979, and since then it has moved from a curiosity to something most general practices screen for routinely on geriatric blood panels. The disease is caused by one or more benign enlargements of the thyroid gland (adenomatous hyperplasia or adenoma) that produce too much thyroxine; thyroid carcinoma is the cause in only a small minority of cats.

This article is the diagnostic and treatment workup — what the thyroid tests actually show, how the diagnosis is confirmed when the numbers are equivocal, and how a veterinarian chooses among methimazole, radioiodine, surgery, and iodine-restricted diet. The single decision that shapes the whole plan is how to treat the hyperthyroidism without harming the kidneys, because unmasking or worsening concurrent chronic kidney disease is the central tradeoff in every hyperthyroid cat. For the medication side of management specifically, see the companion methimazole for cats article; for the blood-pressure angle, see feline hypertension screening.

Quick answer

Feline hyperthyroidism is overproduction of thyroid hormone (T4) by an enlarged thyroid gland, producing the classic signs of weight loss despite a ravenous appetite, increased activity or vocalization, increased thirst and urination, vomiting or diarrhea, and an unkempt coat. Diagnosis rests on an elevated total T4 in a cat with compatible clinical signs; when total T4 is high-normal or equivocal, free T4 by equilibrium dialysis and TSH are added, because about 10% of hyperthyroid cats have a total T4 that sits at the top of the reference range due to early disease or concurrent non-thyroidal illness pulling it down. Four treatments exist — daily methimazole (oral or transdermal), radioiodine (I-131), thyroidectomy, and iodine-restricted diet (Hill's y/d) — and the right one depends on the cat's kidney function, age and anesthetic risk, owner ability to medicate, cost, and whether a cure or lifelong control is the goal. Radioiodine is the only treatment considered curative for the typical cat, but because fixing the thyroid can drop kidney blood flow and "unmask" chronic kidney disease, many cats are stabilized on methimazole first so the kidneys can be assessed once the cat is euthyroid.

How hyperthyroidism behaves, and what it does to the body

Thyroxine (T4) sets the metabolic rate of almost every tissue. When a cat makes too much of it, the body runs too fast: heart rate climbs, blood pressure rises, gut motility increases, muscle and fat are burned for fuel, and the kidneys are forced to filter faster (a high glomerular filtration rate) partly because hyperthyroidism increases cardiac output and renal blood flow. That last point is not a footnote — it is the reason kidney disease and hyperthyroidism are so tangled together in this species. The high filtration rate of the hyperthyroid state can hide chronic kidney disease by keeping blood creatinine and SDMA deceptively low; when the thyroid is then controlled, filtration falls toward normal and the kidney disease becomes visible.

Typical signalment: cats are usually 10 years or older at diagnosis, with no strong sex predisposition. Most have lost weight — sometimes dramatically — while eating more than usual. A thyroid "slip" (a small palpable nodule in the neck) is often present but is not required, and palpation is operator-dependent. A common and important presentation in recent years is the early or "occult" case caught on routine screening before the cat looks sick, which is exactly the scenario that produces borderline lab work.

Confirming the diagnosis: T4, free T4, and TSH

Total T4 (TT4) is the first-line test and the right starting point in almost every cat. It has excellent specificity and good sensitivity: an elevated total T4 in a symptomatic cat is diagnostic. The catch is the roughly 10% of hyperthyroid cats whose total T4 lands high-normal or only mildly elevated. This happens for two reasons — early disease in which hormone output fluctuates in and out of the reference range, and concurrent non-thyroidal illness (kidney disease, infection, anything systemic) that suppresses total T4 downward and can pull a truly hyperthyroid cat's number into the normal range.

When total T4 is equivocal but suspicion remains, the next move is free T4 by equilibrium dialysis (fT4ED). Free T4 is the unbound, active fraction and is less affected by non-thyroidal illness. It is a highly sensitive test — frequently cited at about 98.5% — so a normal free T4 is reassuring and helps rule the disease out. But free T4 must never be used as the sole test to confirm hyperthyroidism, because it can be falsely elevated by non-thyroidal illness on its own. The correct reading is to interpret free T4 together with total T4: a total T4 in the upper third of the reference range combined with a high free T4 is consistent with mild hyperthyroidism, whereas a low or low-normal total T4 with a high free T4 usually points to non-thyroidal illness instead. Equilibrium dialysis specifically is the validated method for cats; other free-T4 assays are not reliable in this species.

TSH rounds out the panel. In hyperthyroidism the pituitary appropriately shuts down TSH production, so a low or undetectable TSH supports the diagnosis when total T4 is borderline. The practical limitation is that a validated feline TSH assay has only been available on a specific platform (the Zomedica TRUFORMA); canine TSH cross-reactivity is less useful in cats, so TSH is helpful when available but is not universally accessible. For genuinely difficult cases, dynamic tests — the T3-suppression test and the TRH-stimulation test — and thyroid scintigraphy (a technetium uptake scan) remain available at referral centers, with scintigraphy considered the gold standard for confirming disease and locating ectopic thyroid tissue.

The take-home: hyperthyroidism is a clinical diagnosis that combines signalment, signs, a thyroid nodule, and the thyroid panel — never a single number in isolation. If the first total T4 is equivocal, retest in two to six weeks rather than overcalling the result.

Choosing a treatment

The four treatments all aim to normalize circulating thyroid hormone, but they differ fundamentally in whether they control the disease or cure it, in reversibility, and in cost.

Methimazole (Felimazole coated tablets, Felanorm oral solution, and since July 2025 an FDA-approved generic coated tablet; transdermal ear-gel compounded forms are also widely used) blocks the enzyme that makes T4. It controls the disease but does not cure it, so it is given for life. It is reversible, inexpensive relative to radioiodine, and safe for almost any cat regardless of age or kidney function, which is exactly why it is the most common first move — and the best tool for the "methimazole trial" used to probe the kidneys (below). Dosing typically starts low (1.25–2.5 mg every 12 hours) and is titrated to total T4 at recheck; most cats are euthyroid within two to three weeks. Side effects occur in roughly 18% of cats on oral methimazole — most often gastrointestinal upset, facial itching (self-induced scratching), liver enzyme elevation, and rare blood-cell drops — and they cluster in the first one to three months, which is why monitoring includes a CBC and chemistry with early rechecks. Carbimazole, used more in Europe and the UK, is a prodrug of methimazole and behaves similarly.

Radioiodine (I-131) is a single subcutaneous injection of radioactive iodine that is selectively taken up by overactive thyroid tissue and destroys it, sparing the normal (suppressed, atrophied) thyroid gland. It treats ectopic and intrathoracic thyroid tissue, requires no general anesthesia, has a cure rate commonly reported around 95%, and resolves the disease permanently in one treatment for most cats. The tradeoffs are cost up front, a several-day hospital stay for radiation safety, limited geographic availability, and the irreversibility — once the thyroid is ablated, the cat can become hypothyroid and need lifelong supplementation, which is a real concern if concurrent kidney disease is present.

Thyroidectomy (surgical removal of the abnormal thyroid lobe or lobes) is curative and fast but requires general anesthesia in an older cat that may have cardiac and kidney disease, and it carries the risk of damaging or removing the adjacent parathyroid glands, which control blood calcium. Hypocalcemia after bilateral thyroidectomy is a serious complication. With the expansion of radioiodine availability, surgery has become less common but remains a good option where radioiodine is unavailable and the cat is a reasonable anesthetic candidate.

Iodine-restricted diet (Hill's Prescription Diet y/d) limits the iodine substrate the gland needs to make T4, so hormone production falls. It avoids medication and anesthesia, but it only works if the cat eats nothing else — no treats, no other food, no hunting, no flavored medications — because even tiny amounts of iodine can break the effect. This makes it a poor fit for outdoor cats, multi-pet households where food can be shared, and cats that need a different therapeutic diet (for example, a renal or GI diet). It is generally reserved for cats that cannot be medicated and cannot access radioiodine.

Cost frames the choice as much as biology does. Methimazole is cheap per month — often under roughly $20 for the tablets — but it is lifelong, and the required monitoring (T4, kidney values, CBC, blood pressure every few months) typically adds $1,000–$2,000 per year in many markets. Radioiodine is a one-time expense — commonly around $1,900–$2,100 all-in at dedicated treatment centers, including the consultation and several days of hospitalization — so it tends to be more economical for a cat with years of life ahead of it, while methimazole is the pragmatic default when cost, travel, or concurrent kidney disease argues against an irreversible treatment. Thyroidectomy falls between the two and is largely a function of what is locally available.

The decision that drives the plan: the kidneys

The defining management question is what happens to kidney function when the thyroid is controlled. Hyperthyroidism raises renal blood flow and filtration; treating it brings filtration back down, which can reveal chronic kidney disease that was hidden by the fast-filtering hyperthyroid state. Treating an irreversible therapy (radioiodine) and then discovering severe kidney disease is the outcome everyone is trying to avoid.

For that reason, the common approach for a newly diagnosed cat is a reversible bridge first: stabilize on methimazole until euthyroid, then reassess kidney values (creatinine, SDMA, urine specific gravity, urine protein-to-creatinine ratio) and blood pressure once the cat is in a normal thyroid state. If kidney function remains acceptable, the cat can proceed to radioiodine for a cure; if significant kidney disease is unmasked, the plan often stays with long-term methimazole at the lowest effective dose. A widely used rule of thumb is to maintain the cat on methimazole for roughly three months after achieving euthyroidism before committing to radioiodine, to give occult kidney disease the best chance to declare itself. Because feline hypertension frequently accompanies hyperthyroidism and persists after treatment, blood pressure is checked at diagnosis and again once the cat is controlled, with amlodipine added when indicated.

Monitoring and what to watch

  • First three months on methimazole: total T4, CBC, and chemistry at roughly two to four weeks and again at six to eight weeks to titrate dose and screen for early side effects, then every three to six months once stable.
  • Kidney surveillance: creatinine, SDMA, and urine specific gravity rechecked once euthyroid and then trended, because kidney disease is commonly unmasked during management.
  • Blood pressure: at diagnosis, after stabilization, and periodically thereafter; treat with amlodipine if hypertensive to protect the eyes, heart, brain, and kidneys.
  • After radioiodine: total T4 (and TSH if hypothyroidism is suspected) rechecked at one month; kidney values and blood pressure rechecked because the filtration rate has changed.
  • Emergency triggers: a cat that goes off food, vomits repeatedly, becomes profoundly weak, collapses, or has seizures may have developed thyrotoxic crisis or — more commonly in a treated cat — hypoglycemia, hypocalcemia (post-surgery), or a kidney/uremic decompensation, and needs same-day care.

Survival reflects treatment choice and comorbidities: cats managed with methimazole alone have a reported median survival of roughly two years, whereas cats stabilized on methimazole and then treated with radioiodine have a substantially longer median survival in published series. With attentive kidney and blood-pressure management, most treated cats return to a good quality of life — but this is a lifelong disease with lifelong monitoring, and the treatment plan is built around protecting the kidneys at every step.

Sources

Topics
Endocrinology
Related Articles